Concert Pharma (NASDAQ: CNCE)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Concert Pharma (NASDAQ: CNCE) through any online brokerage.
The latest price target for Concert Pharma (NASDAQ: CNCE) was reported by Mizuho on Tuesday, October 5, 2021. The analyst firm set a price target for 9.00 expecting CNCE to rise to within 12 months (a possible 108.82% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Concert Pharma (NASDAQ: CNCE) is $4.31 last updated June 24, 2022, 8:00 PM UTC.
There are no upcoming dividends for Concert Pharma.
Concert Pharma’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for Concert Pharma.
Concert Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.